Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram I Mahato

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
Pharmacology & Therapeutics|February 9, 2017
Recent advances in hepatocellular carcinoma therapyRinku Dutta, Ram I Mahato
Nanomedicine (London, England)|April 9, 2008
Role of nanomedicines in cell-based therapeuticsZhaoyang Ye, Ram I Mahato
Cancer Letters|November 4, 2023
Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticlesVirender Kumar, Ram I Mahato
Cancer Letters|February 4, 2024
Drug delivery and targeting to chemoresistant pancreatic cancerVirender Kumar, Ram I Mahato
Molecular Pharmaceutics|May 2, 2017
Bioconjugate Therapeutics: Current Progress and Future PerspectiveFeng Li, Ram I Mahato
Pharmaceutical Research|February 25, 2011
GFAP promoter-driven RNA interference on TGF-β1 to treat liver fibrosisNingning Yang, Ram I Mahato
Advanced Drug Delivery Reviews|April 25, 2009
Gene regulation for effective gene therapy. PrefaceMinhyung Lee, Ram I Mahato
Molecular Pharmaceutics|December 11, 2008
Bipartite vector encoding hVEGF and hIL-1Ra for ex vivo transduction into human isletsRavikiran Panakanti, Ram I Mahato
Molecular Pharmaceutics|April 19, 2014
MicroRNAs and drug resistance in prostate cancersFeng Li, Ram I Mahato
Discovery Medicine|March 20, 2014
Mesenchymal stem cell-based therapy for type 1 diabetesHao Wu, Ram I Mahato
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Pharmacology & Therapeutics|February 9, 2017
Recent advances in hepatocellular carcinoma therapyRinku Dutta, Ram I Mahato
Nanomedicine (London, England)|April 9, 2008
Role of nanomedicines in cell-based therapeuticsZhaoyang Ye, Ram I Mahato
Cancer Letters|November 4, 2023
Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticlesVirender Kumar, Ram I Mahato
Cancer Letters|February 4, 2024
Drug delivery and targeting to chemoresistant pancreatic cancerVirender Kumar, Ram I Mahato
Molecular Pharmaceutics|May 2, 2017
Bioconjugate Therapeutics: Current Progress and Future PerspectiveFeng Li, Ram I Mahato
Pharmaceutical Research|February 25, 2011
GFAP promoter-driven RNA interference on TGF-β1 to treat liver fibrosisNingning Yang, Ram I Mahato
Advanced Drug Delivery Reviews|April 25, 2009
Gene regulation for effective gene therapy. PrefaceMinhyung Lee, Ram I Mahato
Molecular Pharmaceutics|December 11, 2008
Bipartite vector encoding hVEGF and hIL-1Ra for ex vivo transduction into human isletsRavikiran Panakanti, Ram I Mahato
Molecular Pharmaceutics|April 19, 2014
MicroRNAs and drug resistance in prostate cancersFeng Li, Ram I Mahato
Discovery Medicine|March 20, 2014
Mesenchymal stem cell-based therapy for type 1 diabetesHao Wu, Ram I Mahato
Pageof 17